Key facts
- Notable investors include Changxing Fund, Jilin Province Technology Investment Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Changcheng Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Changcheng Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Changcheng Pharmaceutical
Manufacturer of prodrug therapies designed to reduce side effects and improve drug delivery. The company offers a research-driven prodrug development platform focused on multiple tumour cancers, enabling patients to access effective therapies with improved tolerability and practical administration.
- Sector
- Healthcare
- HQ
- Changchun, China
- Founded
- 2016
- Website
- amultipharma.com/
- Ownership
- Privately Held (backing)
Changcheng Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Changcheng Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Changcheng Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.